Solace European Confirmatory Trial

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

January 31, 2017

Conditions
Stress Urinary Incontinence
Interventions
DEVICE

Solace Bladder Control System

Subjects may undergo treatment every 12 months until study completion.

DEVICE

Solace Sham Treatment

Sham procedure that resembles treatment with the Solace Bladder Control System

Trial Locations (7)

2650

University of Antwerp Hospital (Universitair Ziekenhuis Antwerpen), Antwerp

80131

"University of Naples (Università Degli Studi Di Napoli Federico II )", Naples (Napoli)

B-1090

UZ Brussel, Brussels

Unknown

UZ Gent, Ghent

Universita Campus Bio-medico di Roma, Rome

Catharina Ziekenhuis, Eindhoven

6229 HX

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Solace Therapeutics, Inc.

INDUSTRY

NCT01676662 - Solace European Confirmatory Trial | Biotech Hunter | Biotech Hunter